Healio

‘Glass half full’: Next-generation sequencing for advanced cancer lags, but rates improving

Nearly half of people diagnosed with advanced cancer over a recent 5-year period did not undergo next-generation sequencing, according to results of a retrospective cohort study.Rates improved over ...
Morningstar

Ultima Genomics Introduces the Next Generation of Sequencing at Scale with the Launch of the UG200™ Series and Next Generation Solaris 2.0 Workflows Delivering Higher Output ...

Twice the output, half the runtime, and half the footprint of the UG 100® with greater flexibility and improved genomic coverage Introducing two new high-throughput instrument configurations ...
Regulatory Affairs Professionals Society

FDA drafts guidance on using next-generation sequencing to assess gene therapy safety

The US Food and Drug Administration (FDA) has released draft guidance on how sponsors can utilize next-generation sequencing ...
The Scientist

Ultima Genomics Introduces the Next Generation of Sequencing at Scale with the Launch of the UG200™ Series and Next Generation Solaris 2.0 Workflows

Ultima Genomics, Inc., a developer of ultra-high-throughput sequencing systems, continues its mission to enable sequencing at scale with the unveiling of the UG200 Series and next generation Solaris 2 ...